Garner is a behavioral intervention scientist and an assistant professor of nutritional sciences.

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Nasdaq’s determination is based on the Company meeting all other applicable requirements for listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s ...

Springworks Therapeutics shares surged over 36% Monday, reaching levels last seen in mid-April 2022, as buyout speculation ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

For the first time in 30 years, the Food and Drug Administration is updating its claim on what food products can use the word “healthy” on their labels. Some will have to lose that ...

The company hopes to list its shares on Nasdaq under the symbol AAPG. Lead bookrunners ... Ascentage (AAPG) hopes to file for FDA approval of the product in 2026.

Kestra Medical Technologies, a Kirkland, Wash.-based company selling cardiac monitoring and therapeutic devices, filed for an ...

Beta Bionics (BBNX) hopes to list its shares on Nasdaq under the symbol BBNX ... The product has been approved by the FDA for the treatment of type 1 diabetes. Beta Bionics (BBNX) hopes to ...

The FDA’s decision is symbol of triumph for consumer safety groups ... Image credit: Pinterest Red Dye No. 3, formulated using petroleum, was approved for use in foods in 1907. The U.S FDA first ...

It's approved by the FDA for both single and repeated-use food ... To identify it, look for the number 5 recycling symbol.